Serum Institute to Manufacture Oxford Ebola Vaccine with CEPI Funding
The “Plug-and-Play” Revolution: Why Platform Technology is the Future of Biodefense The recent partnership between the University of Oxford and the Serum Institute of India (SII) to tackle the Bundibugyo Ebola strain isn’t just a localized medical response; It’s a blueprint for the future of global health security. By utilizing the ChAdOx1 platform—the same technology … Read more
